Update of the Preventive Antibiotics in Stroke Study (PASS): Statistical analysis plan

Trials

Volumn 15, Issue 1, 2014, Pages

  Westendorp, Willeke F ^a   Vermeij, Jan Dirk ^a   Dippel, Diederik W J ^b   Dijkgraaf, Marcel G W ^a   van der Poll, Tom ^a   Prins, Jan M ^a   Vermeij, Frederique H ^c   Roos, Yvo B W E M ^a   Brouwer, Matthijs C ^a   Zwinderman, Aeilko H ^a   van de Beek, Diederik ^a   Nederkoorn, Paul J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c SINT FRANCISCUS GASTHUIS   (Netherlands)

Author keywords

antibiotics; infection; randomized clinical trial; statistical analysis plan; stroke

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA SECRETASE INHIBITOR; CEFTRIAXONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; FUNCTIONAL STATUS; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION; INFECTION PREVENTION; INTENTION TO TREAT ANALYSIS; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHLEBITIS; PNEUMONIA; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SECONDARY ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL ANALYSIS PLAN; STROKE PATIENT; URINARY TRACT INFECTION; BACTERIAL INFECTIONS; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPLICATION; CONVALESCENCE; COST BENEFIT ANALYSIS; DISABILITY; DRUG ADMINISTRATION; DRUG COST; ECONOMICS; METHODOLOGY; MICROBIOLOGY; MORTALITY; MULTICENTER STUDY; NETHERLANDS; PATHOPHYSIOLOGY; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; STROKE; TIME; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CEFTRIAXONE; CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; DATA INTERPRETATION, STATISTICAL; DISABILITY EVALUATION; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; NETHERLANDS; ODDS RATIO; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECOVERY OF FUNCTION; RESEARCH DESIGN; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84908654372     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-382     Document Type: Article

References (27)

1. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C, . Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014, 383:245-254. 10.1016/S0140-6736(13)61953-4, 4181600, 24449944, Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group.
2. Vermeij FH, op Reimer WJ S, de Man P, van Oostenbrugge RJ, Franke CL, de Jong G, de Kort PL, Dippel DW, . Netherlands Stroke Survey Investigators Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis 2009, 27:465-471. 10.1159/000210093, 19329851, Netherlands Stroke Survey Investigators.
3. Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG, van de Beek D. Post-stroke infection: A systematic review and meta-analysis. BMC Neurol 2011, 11:110. 10.1186/1471-2377-11-110, 3185266, 21933425.
4. van de Beek D, Wijdicks EF, Vermeij FH, de Haan RJ, Prins JM, Spanjaard L, Dippel DW, Nederkoorn PJ. Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis. Arch Neurol 2009, 66:1076-1081.
5. Westendorp WF, Vermeij JD, Vermeij F, Den Hertog HM, Dippel DW, van de Beek D, Nederkoorn PJ. Antibiotic therapy for preventing infections in patients with acute stroke. Cochrane Database Syst Rev 2012, 1. CD008530.
6. Westendorp WF, Vermeij JD, Vermeij F, Den Hertog HM, Dippel DW, van de Beek D, Nederkoorn PJ. Preventive antibiotics in stroke study: rationale and protocol for a randomised trial. Int J Stroke 2011, 6:159-163. 10.1111/j.1747-4949.2010.00555.x, 21371281.
7. Westendorp WF, Vermeij JD, van Geloven N, Dippel DW, Dijkgraaf MG, van der Poll T, Prins JM, Spanjaard L, Vermeij FH, Nederkoorn PJ, van de Beek D. Update on the Preventive Antibiotics in Stroke Study (PASS): a randomised controlled phase 3 clinical trial. Trials 2014, 15:133. 10.1186/1745-6215-15-133, 4000143, 24750904.
8. National Institute of Health National Institute of Neurological Disorders and Stroke. Stroke Scale 2014, National Institute of Health.
9. ALEA Software for randomisation in clinical trials. ALEA Version - Release: 2.2 build: 2070
10. Rizopoulos D, Lesaffre E. Introduction to the special issue on joint modelling techniques. Stat Methods Med Res 2014, 23:3-10. 10.1177/0962280212445800, 24419399.
11. Janssen PM, Visser NA, Dorhout Mees SM, Klijn CJ, Algra A, Rinkel GJ. Comparison of telephone and face-to-face assessment of the modified Rankin Scale. Cerebrovasc Dis 2010, 29:137-139. 10.1159/000262309, 19955737.
12. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332. 10.1016/j.ajic.2008.03.002, 18538699.
13. World Health Organization ATC/DDD Index 2014, http://www.whocc.no/atc_ddd_index/, last updated 2013-12-19, World Health Organization.
14. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, . RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009, 361:1139-1151. 10.1056/NEJMoa0905561, 19717844, RE-LY Steering Committee and Investigators.
15. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011, 365:981-992. 10.1056/NEJMoa1107039, 21870978.
16. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011, 365:883-891. 10.1056/NEJMoa1009638, 21830957.
17. Gray LJ, Bath PM, Collier T. Should stroke trials adjust functional outcome for baseline prognostic factors?. Stroke 2009, 40:888-894.
18. Kahan BC, Jairath V, Dore CJ, Morris TP. The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies. Trials 2014, 15:139. 10.1186/1745-6215-15-139, 4022337, 24755011.
19. Johnston KC, Connors AF, Wagner DP, Knaus WA, Wang X, Haley EC. A predictive risk model for outcomes of ischemic stroke. Stroke 2000, 31:448-455. 10.1161/01.STR.31.2.448, 10657421.
20. Melsen WG, Rovers MM, Groenwold RH, Bergmans DC, Camus C, Bauer TT, Hanisch EW, Klarin B, Koeman M, Krueger WA, Lacherade JC, Lorente L, Memish ZA, Morrow LE, Nardi G, van Nieuwenhoven CA, O'Keefe GE, Nakos G, Scannapieco FA, Seguin P, Staudinger T, Topeli A, Ferrer M, Bonten MJ. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis 2013, 13:665-671. 10.1016/S1473-3099(13)70081-1, 23622939.
21. Thöne-Reineke C, Neumann C, Namsolleck P, Schmerbach K, Krikov M, Schefe JH, Lucht K, Hörtnagl H, Godes M, Müller S, Rumschüssel K, Funke-Kaiser H, Villringer A, Steckelings UM, Unger T. The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke. J Hypertens 2008, 26:2426-2435. 10.1097/HJH.0b013e328313e403, 19008722.
22. Hawkey PM. The growing burden of antimicrobial resistance. J Antimicrob Chemother 2008, 62(Suppl 1):i1-i9.
23. Baquero F, Negri MC, Morosini MI, Blazquez J. Antibiotic-selective environments. Clin Infect Dis 1998, 27(Suppl 1):S5-S11.
24. Schechner V, Temkin E, Harbarth S, Carmeli Y, Schwaber MJ. Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clin Microbiol Rev 2013, 26:289-307. 10.1128/CMR.00001-13, 3623381, 23554418.
25. Harms H, Prass K, Meisel C, Klehmet J, Rogge W, Drenckhahn C, Göhler J, Bereswill S, Göbel U, Wernecke KD, Wolf T, Arnold G, Halle E, Volk HD, Dirnagl U, Meisel A. Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS ONE 2008, 3:e2158. 10.1371/journal.pone.0002158, 2373885, 18478129.
26. de Smet AM, Kluytmans JA, Blok HE, Mascini EM, Benus RF, Bernards AT, Kuijper EJ, Leverstein-van Hall MA, Jansz AR, de Jongh BM, van Asselt GJ, Frenay IH, Thijsen SF, Conijn SN, Kaan JA, Arends JP, Sturm PD, Bootsma MC, Bonten MJ. Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. Lancet Infect Dis 2011, 11:372-380. 10.1016/S1473-3099(11)70035-4, 21420908.
27. McHugh GS, Butcher I, Steyerberg EW, Marmarou A, Lu J, Lingsma HF, Weir J, Maas AI, Murray GD. A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project. Clin Trials 2010, 7:44-57. 10.1177/1740774509356580, 20156956.